Drug Profile
Research programme: cardiopulmonary therapeutic - Dr Reddy's/SCOLR
Latest Information Update: 04 Aug 2010
Price :
$50
*
At a glance
- Originator Dr Reddys Laboratories; SCOLR Pharma
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 24 Oct 2007 Preclinical trials in Undefined indication in India (PO)
- 24 Oct 2007 Preclinical trials in Undefined indication in USA (PO)